• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[糖尿病患者心血管疾病的管理:2023年欧洲心脏病学会指南]

[Management of cardiovascular diseases in patients with diabetes : ESC guidelines 2023].

作者信息

Marx Nikolaus, Müller-Wieland Dirk, Verket Marlo, Schütt Katharina

机构信息

Medizinische Klinik I - Kardiologie, Angiologie und Internistische Intensivmedizin, Uniklinik RWTH Aachen, Pauwelsstr. 30, 52074, Aachen, Deutschland.

出版信息

Herz. 2024 Feb;49(1):15-18. doi: 10.1007/s00059-023-05218-x. Epub 2023 Oct 25.

DOI:10.1007/s00059-023-05218-x
PMID:37878038
Abstract

Patients with diabetes mellitus have an increased risk for the development of cardiovascular diseases. The presence of both comorbidities has a major impact not only on the prognosis of the patients but is also decisive for the implementation of evidence-based treatment strategies for reduction of the cardiovascular risk. The new guidelines of the European Society of Cardiology (ESC) were published in 2023 and provide clear recommendations for the management of cardiovascular diseases in patients with diabetes. The most relevant aspects of these guidelines are summarized in the following overview article.

摘要

糖尿病患者发生心血管疾病的风险增加。这两种合并症的存在不仅对患者的预后有重大影响,而且对于实施降低心血管风险的循证治疗策略也起着决定性作用。欧洲心脏病学会(ESC)的新指南于2023年发布,为糖尿病患者心血管疾病的管理提供了明确建议。以下综述文章总结了这些指南中最相关的方面。

相似文献

1
[Management of cardiovascular diseases in patients with diabetes : ESC guidelines 2023].[糖尿病患者心血管疾病的管理:2023年欧洲心脏病学会指南]
Herz. 2024 Feb;49(1):15-18. doi: 10.1007/s00059-023-05218-x. Epub 2023 Oct 25.
2
Joint ESC/EASD guidelines on diabetes, where are we now and where should we go?ESC/EASD 联合糖尿病指南:我们现在在哪里,我们应该去哪里?
Curr Vasc Pharmacol. 2012 Nov;10(6):690-2. doi: 10.2174/157016112803520891.
3
[Interpretation of 2023 European Society of Cardiology (ESC) Guidelines for the management of cardiovascular disease in patients with diabetes].[2023年欧洲心脏病学会(ESC)糖尿病患者心血管疾病管理指南解读]
Zhonghua Xin Xue Guan Bing Za Zhi. 2023 Dec 24;51(12):1273-1277. doi: 10.3760/cma.j.cn112148-20230914-00161.
4
Nationwide cardiovascular risk categorization: applying the European Society of Cardiology guidelines to the Swedish National Diabetes Register.全国心血管风险分类:将欧洲心脏病学会指南应用于瑞典国家糖尿病登记处。
Eur J Prev Cardiol. 2023 May 9;30(7):546-551. doi: 10.1093/eurjpc/zwac308.
5
[New ESC guidelines 2019 "Diabetes, prediabetes and cardiovascular diseases" : Paradigm shift in reduction of cardiovascular risk in patients with diabetes mellitus].[2019年欧洲心脏病学会新指南“糖尿病、糖尿病前期与心血管疾病”:糖尿病患者心血管风险降低方面的范式转变]
Herz. 2019 Dec;44(8):684-687. doi: 10.1007/s00059-019-04860-8.
6
ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD - summary.欧洲心脏病学会(ESC)与欧洲糖尿病研究协会(EASD)合作制定的糖尿病、糖尿病前期和心血管疾病指南——总结
Diab Vasc Dis Res. 2014 May;11(3):133-73. doi: 10.1177/1479164114525548.
7
The '10 commandments' for the 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes.2023年欧洲心脏病学会糖尿病患者心血管疾病管理指南的“十诫”
Eur Heart J. 2024 Apr 14;45(15):1298-1300. doi: 10.1093/eurheartj/ehad881.
8
Comparison of the European and US guidelines for lipid-lowering therapy in primary prevention of cardiovascular disease.比较欧洲和美国指南中的降脂治疗方案在心血管疾病一级预防中的应用。
Eur J Prev Cardiol. 2023 Nov 30;30(17):1856-1864. doi: 10.1093/eurjpc/zwad193.
9
The Fifth Annual Heart in Diabetes Conference (Part 1).
J Diabetes. 2021 Dec;13(12):946-948. doi: 10.1111/1753-0407.13231. Epub 2021 Oct 19.
10
Comments on the 2023 ESC guidelines on cardiovascular disease in patients with diabetes.
Rev Esp Cardiol (Engl Ed). 2024 Mar;77(3):196-200. doi: 10.1016/j.rec.2023.11.005. Epub 2023 Nov 24.

引用本文的文献

1
Effect of semaglutide on arrhythmic, major cardiovascular, and microvascular outcomes in patients with type 2 diabetes: a systematic review and meta-analysis.司美格鲁肽对2型糖尿病患者心律失常、主要心血管及微血管结局的影响:一项系统评价与荟萃分析
Front Endocrinol (Lausanne). 2025 Aug 26;16:1554795. doi: 10.3389/fendo.2025.1554795. eCollection 2025.
2
Machine learning models for assessing risk factors affecting health care costs: 12-month exercise-based cardiac rehabilitation.机器学习模型评估影响医疗保健费用的风险因素:基于运动的 12 个月心脏康复。
Front Public Health. 2024 May 28;12:1378349. doi: 10.3389/fpubh.2024.1378349. eCollection 2024.

本文引用的文献

1
Mechanisms of benefits of sodium-glucose cotransporter 2 inhibitors in heart failure with preserved ejection fraction.钠-葡萄糖共转运蛋白 2 抑制剂在射血分数保留心力衰竭中的获益机制。
Eur Heart J. 2023 Oct 1;44(37):3640-3651. doi: 10.1093/eurheartj/ehad389.
2
2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD.2019年欧洲心脏病学会(ESC)与欧洲糖尿病研究协会(EASD)合作制定的糖尿病、糖尿病前期和心血管疾病指南。
Eur Heart J. 2020 Jan 7;41(2):255-323. doi: 10.1093/eurheartj/ehz486.